BATTINI, VERA
BATTINI, VERA
Dipartimento di Scienze Biomediche e Cliniche
Umbrella Review: Association Between Antipsychotic Drugs and Metabolic Syndrome Hallmarks in Children and Adolescents
2023 C. Carnovale, V. Battini, C. Santoro, M.P. Riccio, S. Carucci, M. Nobile, P. Formisano, C. Bravaccio, A. Zuddas, E. Clementi, M. Pozzi, S. Pisano
The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase
2023 V. Battini, R.P. Van Manen, M. Gringeri, G. Mosini, G. Guarnieri, A. Bombelli, M. Pozzi, M. Nobile, S. Radice, E. Clementi, C. Carnovale
A novel approach for pharmacological substantiation of safety signals using plasma concentrations of medication and administrative/healthcare databases: A case study using Danish registries for an FDA warning on lamotrigine
2023 W. Wang, V. Battini, C. Carnovale, R. Noordam, K.W. van Dijk, K.H. Kragholm, D. van Heemst, H. Soeorg, M. Sessa
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study
2023 M. Fusaroli, V. Giunchi, V. Battini, M. Gringeri, R. Rimondini, M. Menchetti, S. Radice, M. Pozzi, M. Nobile, E. Clementi, F. De Ponti, C. Carnovale, E. Raschi, E. Poluzzi
Barriers to the use of three-month Paliperidone Palmitate formulation: a study from an Italian real-world setting
2023 G. Cirnigliaro, V. Battini, R. Cafaro, G. Mosini, S. Vanzetto, T. Prodi, M. Macellaro, R. Leuzzi, D. Conti, C. Carnovale, B. Dell'Osso
On the potential of drug repurposing in dysphagia treatment: New insights from a real-world pharmacovigilance study and a systematic review
2023 V. Battini, S. Rocca, G. Guarnieri, A. Bombelli, M. Gringeri, G. Mosini, M. Pozzi, M. Nobile, S. Radice, E. Clementi, A. Schindler, C. Carnovale, N. Pizzorni
Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System
2023 V. Battini, C. Carnovale, E. Clementi, M. Sessa
Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS
2023 V. Battini, G. Cirnigliaro, L. Giacovelli, M. Boscacci, S. MASSARA MANZO, G. Mosini, G. Guarnieri, M. Gringeri, B. Benatti, E.G.I. Clementi, D. Bernardo, C. Carnovale
The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression
2023 V. Battini, G. Cirnigliaro, R. Leuzzi, E. Rissotto, G. Mosini, B. Benatti, M. Pozzi, M. Nobile, S. Radice, C. Carnovale, B. Dell'Osso, E. Clementi
Antibiotic-Induced Neutropenia in Pediatric Patients: New Insights From Pharmacoepidemiological Analyses and a Systematic Review
2022 V. Battini, A. Mari, M. Gringeri, F. Casini, F. Bergamaschi, G. Mosini, G. Guarnieri, M. Pozzi, M. Nobile, G.V. Zuccotti, E. Clementi, S. Radice, V. Fabiano, C. Carnovale
Reply to: correspondence on "Herpes Zoster and Simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis"
2022 M. Gringeri, V. Battini, G. Cammarata, G. Mosini, G. Guarnieri, C. Leoni, M. Pozzi, S. Radice, E. Clementi, C. Carnovale
Long-term COVID symptoms, work ability and fitness to work in healthcare workers hospitalized for Sars-CoV-2 infection
2022 M. Mendola, M. Leoni, Y. Cozzi, A. Manzari, F. Tonelli, F. Metruccio, L. Tosti, V. Battini, I. Cucchi, M.C. Costa, P. Carrer
Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis
2022 M. Gringeri, V. Battini, G. Cammarata, G. Mosini, G. Guarnieri, C. Leoni, M. Pozzi, S. Radice, E. Clementi, C. Carnovale
Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: A real-world evidence study and systematic review
2022 C. Carnovale, V. Battini, M. Gringeri, M. Volonté, M.C. Uboldi, A. Chiarenza, G. Passalacqua
Inflammasome Targeted Therapy in Pregnancy: New Insights From an Analysis of Real-World Data From the FAERS Database and a Systematic Review
2021 C. Carnovale, E. Tombetti, V. Battini, F. Mazhar, S. Radice, M. Nivuori, E. Negro, S. Tamanini, A. Brucato
The impact of anti-TNFα agents on weight-related changes : new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database
2021 F. Mazhar, V. Battini, M. Gringeri, M. Pozzi, G. Mosini, A.M.N. Marran, S. Akram, R.P. van Manen, S. Radice, E. Clementi, C. Carnovale
Antiemetic Drugs during Pregnancy : What Can We Learn from Spontaneous Reporting System Database Analyses?
2021 F. Mazhar, V. Battini, C. Carnovale
Severe hypoglycemia in children treated with nadolol: A case report and FDA adverse event reporting system (FAERS) database analysis
2021 F. Bergamaschi, M. Fumagalli, S. Mannarino, P. Carlucci, S. Radice, M. Gringeri, G. Mosini, C. Carnovale, V. Battini, V. Fabiano
Hyponatremia Following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports From the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review
2021 F. Mazhar, V. Battini, M. Pozzi, E. Invernizzi, G. Mosini, M. Gringeri, A. Capuano, C. Scavone, S. Radice, E. Clementi, C. Carnovale
Preliminary evidence on the safety profile of BNT162b2 (Comirnaty): new insights from data analysis in EudraVigilance and adverse reaction reports from an Italian health facility
2021 M. Gringeri, G. Mosini, V. Battini, G. Cammarata, G. Guarnieri, C. Carnovale, E. Clementi, S. Radice